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Abstract — The International Society of Arthroplasty Registries 
(ISAR) Steering Committee established the Patient-Reported 
Outcome Measures (PROMs) Working Group to convene, evalu-
ate, and advise on best practices in the selection, administration, 
and interpretation of PROMs and to support the adoption and 
use of PROMs for hip and knee arthroplasty in registries world-
wide. The 2 main types of PROMs include generic (general health) 
PROMs, which provide a measure of general health for any health 
state, and specifi c PROMs, which focus on specifi c symptoms, dis-
eases, organs, body regions, or body functions. The establishment 
of a PROM instrument requires the fulfi llment of methodological 
standards and rigorous testing to ensure that it is valid, reliable, 
responsive, and acceptable to the intended population.
A survey of the 41 ISAR member registries showed that 8 regis-
tries administered a PROMs program that covered all elective hip 
or knee arthroplasty patients and 6 registries collected PROMs 
for sample populations; 1 other registry had planned but had not 
started collection of PROMs. The most common generic instru-
ments used were the EuroQol 5 dimension health outcome survey 
(EQ-5D) and the Short Form 12 health survey (SF-12) or the 
similar Veterans RAND 12-item health survey (VR-12).  The most 
common specifi c PROMs were the Hip disability and Osteoarthri-
tis Outcome Score (HOOS), the Knee injury and Osteoarthritis 
Outcome Score (KOOS), the Oxford Hip Score (OHS), the Oxford 
Knee Score (OKS), the Western Ontario and McMaster Universi-
ties Arthritis Index (WOMAC), and the University of California 
at Los Angeles Activity Score (UCLA). ■
Establishment of Working Group team
In early 2014, the International Society of Arthroplasty Reg-
istries (ISAR) Steering Committee established 5 working 
groups to further enhance the aims of the society: (1) the 
Bylaws and Future Funding Committee, (2) the Data Qual-
ity and Harmonization Group, (3) the Scientifi c Committee, 
(4) the Quality Improvement Committee, and (5) the Patient-
Reported Outcome Measures (PROMs) Working Group. The 
composition of the PROMs Working Group members was bal-
anced to cover different continents, registry affi liations, and 
professions. This report reviews the rationale and features of 
PROMs for use in arthroplasty registries, and describes the 
results of a survey of arthroplasty registries about their current 
use of PROMs for hip and knee arthroplasty.
Rationale of work
There are currently several large regional or national programs 
that collect and monitor PROMs before and after arthroplasty 
surgery (Department of Health 2008, Rolfson et al. 2011a, 
2011b, Franklin et al. 2012). These PROMs complement tra-
ditional outcomes data such as complications, adverse events, 
reoperations, and revisions. Although primary outcomes after 
joint replacement include pain relief and improved function, 
clinician-based tests may be biased and may not be valid to 
describe patient self-perceptions of health status. Despite 
having limitations, PROMs are the best tools available to mea-
sure patient-centered outcomes objectively. 
Electronic Supplementum no 362: ISAR meeting Gothenburg 2015, Sweden
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The greater emphasis on PROMs in routine care during the 
last few years has been stimulated by the introduction of the 
concept of value-based healthcare, in which decisions about 
the best ways to deliver healthcare should be based on fac-
tors that add value for the patient (Porter 2010). Traditional 
measures are necessary, but PROMs are fundamental in under-
standing and evaluating healthcare from a value-based stand-
point. Although revision surgery and major adverse events are 
rare complications, improvements are necessary because 10% 
to 20% of patients who have hip or knee replacement are dis-
satisfi ed with the outcome, mainly because of persistent pain 
and limited function (Rolfson et al. 2011a, Dunbar et al. 2013). 
Mission and aim
The ISAR PROMs Working Group is an international panel 
of collaborators that was organized to convene, evaluate, and 
advise on best practices in the selection, administration, and 
interpretation of PROMs and to support the adoption and use 
of PROMs in hip and knee arthroplasty registries worldwide. 
Specifi c aims include advising about (1) which PROMs are 
best and most appropriate to use, (2) when to capture PROMs 
in relation to treatment, (3) data collection methods, (4) 
approach to analysis, and (5) optimal ways to present results. 
The Working Group also aims to (1) promote harmonization, 
to allow direct comparisons within and between centers over 
time, (2) avoid excessive complexity, and (3) ensure that stan-
dards are guided by research agendas and not by the special 
interests of companies or other funders of healthcare.  
Definitions
Patient-reported outcomes and patient-reported out-
come measures
A patient-reported outcome is defi ned as any report of a 
patient’s health status that comes directly from the patient 
without interpretation by others. The PROMs are standard-
ized instruments designed to measure specifi c phenomena or 
constructs of the health status of patients in defi ned popula-
tions (U.S. Department of Health and Human Services FDA 
Center for Drug Evaluation and Research et al. 2006). The 
term outcome may cause confusion because it implies a mea-
surement that occurs only after an intervention. By defi nition, 
true outcomes involve the measurement of change and typi-
cally require repeated measures before—and/or at intervals 
after—interventions or during the disease course. Therefore, 
cross-sectional patient-reported measurements after treatment 
do not generate true outcomes.
Generic and speciﬁ c patient-reported outcome measures
There are 2 main types of PROMs that are distinguished by 
different levels of focus. Generic (or general health) instru-
ments are designed to provide a measure of general health 
for any health state, regardless of the presence or absence 
of illness, disability, or specifi c symptoms. Generic PROMs 
describe a patient’s global health status that is comparable 
across different conditions.
Specifi c PROMs focus on specifi c symptoms, diseases, 
organs, body regions, or body functions. The specifi c PROMs 
may also be specifi cally designed to measure the effect of a 
specifi c intervention or treatment.
Methodological standards for the establishment of 
patient-reported outcome measures instruments
The establishment of a PROMs instrument requires the fulfi ll-
ment of a set of methodological standards. The involvement 
of patients with methods such as interviews or focus groups 
to generate item content is important to ensure that the instru-
ment will refl ect the patient’s standpoint and have valid con-
tent (U.S. Department of Health and Human Services FDA 
Center for Drug Evaluation and Research et al. 2006). The 
instrument must be tested rigorously to ensure that it is valid, 
reliable, responsive, and acceptable to the intended popula-
tion. These properties are not fi xed properties of an instrument 
but may relate to the population, the condition, or the treat-
ment studied. The timing of questionnaire completions rela-
tive to the date of intervention may also affect the instrument’s 
measurement properties. 
After the content of a PROMs instrument has been estab-
lished by the developers, none of the wording in the PROM 
may be changed, including word or item order. In addition to 
copyright issues, small changes in wording may change the 
perceived meaning of the items, and this may affect the mea-
surement properties (Wild et al. 2005, Rothman et al. 2009). 
Validity
Validity is the ability of an instrument to measure the intended 
outcome. A valid instrument adequately captures particular 
aspects of a person’s health such as pain, mobility, or social 
functioning. Validity is an indication of the extent to which 
an assessment measures a particular construct in a particular 
situation, and a measure may be valid for one purpose but not 
another.
The different types of validity include content validity, 
which is the extent to which an instrument measures the 
intended concept. Content validity is specifi c to the population 
and treatment of interest. Content validity must be established 
before other measurement properties are evaluated, because 
other types of validity or reliability cannot overcome problems 
in content validity. Evidence to support content validity comes 
from qualitative studies that determine whether the items and 
domains of an instrument are appropriate and comprehensive 
relative to the intended measurement concept, population, and 
application. For PROMs, items and domains should refl ect 
concerns of importance to most patients in the study. Content 
validity can be increased with (1) patient input in item gen-
eration, and (2) evaluation of patient understanding through 
cognitive interviews and pre-tests. 
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Criterion validity compares an instrument’s measurement 
properties to a known standardized measure of the same con-
struct, but such a measure may not exist. Construct validity is 
the extent to which an instrument forms pre-specifi ed logical 
relations such as correlations between items or domains, and 
correlations to other established instruments or characteristics 
of patients or patient groups. 
Reliability
Reliability has 2 elements: internal consistency and repeat-
ability (also known as reproducibility). Internal consistency is 
the correlation between different items within a domain, and is 
a measure of the extent to which these items measure the con-
cept of interest. Internal consistency is measured with Cron-
bach’s alpha, a summary correlation; a high Cronbach alpha 
may indicate redundancy, and a low Cronbach alpha (< 0.70) 
may indicate inconsistency. However, the optimal correlation 
as expressed with Cronbach’s alpha may be diffi cult to defi ne. 
Repeatability (also known as test-retest reliability) is the 
stability of a measure over time. Repeatability is a measure 
of the random variability in a patient’s responses to the same 
item when repeated measures are assessed under the same 
conditions and no real change has occurred. Repeatability can 
be evaluated with different statistical tests and is considered 
acceptable when the intraclass correlation coeffi cient is > 0.70.
Responsiveness
Responsiveness is defi ned as an instrument’s ability to detect 
change when change has occurred. Adequate responsiveness 
is important for an instrument that is used to assess clinical 
changes. When a patient reports that a change has occurred, 
but the PROMs instrument score does not change, then the 
instrument may have inadequate ability to detect change or 
questionable validity. 
Assessments of responsiveness of a measure require 
repeated assessments over time when the patient’s condition 
of interest has changed. Condition- or context-specifi c mea-
sures are more responsive to changes in the condition of inter-
est than generic measures, which may respond to other co-
existing conditions increasingly with time.
In addition to showing that an instrument may detect 
change, it is useful to have an estimate of the minimal change 
of a measure, which is the smallest change that indicates that 
an important or meaningful change has occurred. An estimate 
of minimal change is needed to determine the real clinical or 
subjective meaning of any observed changes, whether or not 
the changes are statistically signifi cant. Statistical signifi cance 
depends, in part, on sample size. A small, clinically irrelevant, 
change may be statistically signifi cant when the sample size 
is large. A large clinically relevant change may not be statisti-
cally signifi cant in a small study (Petersen 2001). 
Minimal change can be estimated as either the smallest 
amount of change that is of relevance to patients (minimal 
clinically important difference (MCID)) or the amount of 
change that is beyond simple measurement error (minimal 
detectable change (MDC)). The MCID is termed anchor-
based, as it uses anchor questions to establish minimal change, 
and the MDC is distribution-based, i.e. based on statistical 
characteristics of the sample at issue. The MCID and MDC 
produce different estimates, but it is important that an estimate 
of minimal change that is produced using an anchor is larger 
than the measurement error of the instrument to confi rm that 
the change is real (Jaeschke et al. 1989, Wyrwich et al. 1999). 
Acceptability and feasibility
To optimize an instrument’s properties, it is important to con-
sider the burden to respondents and healthcare personnel in 
completing and administering questionnaires. Shorter mea-
sures that are written in clear, unambiguous language will 
encourage a higher frequency of response, which is often used 
as supporting evidence of the acceptability of a questionnaire. 
Translations and cultural differences in response patterns
The translation of a validated PROMs instrument into dif-
ferent languages requires a formal methodological approach 
and specifi c expertise (Wild et al. 2005). Such methods typi-
cally include consideration and testing of cultural equivalence, 
especially when there is no exact word or concept available in 
the target language or culture to match the word or concept 
that is used in the primary-language version of the measure 
being translated. Several steps are involved in the process of 
translating a PROMs instrument into another language, such 
as forward translation, reconciliation, back translation, harmo-
nization, review, and cognitive debriefi ng (Wild et al. 2005).
The use of a PROMs instrument with different platforms, 
such as electronic (ePRO/ePROM) and hard-copy versions, 
may not be straightforward and may require changes in format 
or minor word changes, including instructions for completion. 
Recommendations for best practice are available for modifi ca-
tion of the platform, including how much change in wording 
is considered minor (Coons et al. 2009, Rothman et al. 2009). 
The quality may vary between different translated or elec-
tronic versions of a PROMs instrument. When a translated 
version of a PROMs instrument is required for a specifi c lan-
guage, it is therefore important to confi rm that proper methods 
have been used and that the license holder supports a particu-
lar translated version. Caution is recommended in developing 
or adopting specifi c versions of ePROMs.
Other patient-reported measures related to health 
outcomes
Satisfaction and similar measures: In addition to measures that 
directly address health status, there are useful patient-reported 
measures related to health outcomes such as measures of satis-
faction with treatment effects, fulfi llment of expectations, and 
willingness to repeat or recommend treatment to others. These 
interrelated measures are not true PROMs, by defi nition, and 
can be used only after an intervention or to evaluate some-
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thing that has already occurred. Nevertheless, satisfaction 
and similar measures are associated with changes in PROMs 
scores and the patient’s experience of care delivery. When true 
PROMs have inherent limitations that fail to determine treat-
ment success, satisfaction items may be useful adjuncts. 
Health transition: Health transition items are another cate-
gory of patient-reported measures that address a self-perceived 
change over a defi ned period for a given construct. Health tran-
sitions can be used only retrospectively. Health transition items 
are often used in conjunction with health status measures, and 
may be incorporated into questions within a PROMs instru-
ment, such as the Veterans RAND 12-item health survey (VR-
12) question: “Compared to 1 year ago, how would you rate 
your physical health in general now?”, which has 5 response 
options ranging from “much better” to “much worse”. How-
ever, scores of health transition items are usually not incor-
porated into the overall PROMs score. As indicators of clini-
cally important improvement or deterioration, transition items 
are commonly used to anchor changes in a particular scale. 
Response bias may occur from diffi culty in recalling previous 
states and the tendency to accommodate, or due to changes in 
an individual regarding internal standards, values, or concep-
tualization—which is also known as response shift. 
Survey of collection of patient-reported outcome 
measures in arthroplasty registries
An e-mail survey was administered in September 2014 to full 
ISAR member registries (n = 12) and associate ISAR member 
registries (n = 29) to determine the current use of PROMs in 
arthroplasty registries. 8 registries administered a PROMs 
program that covered all elective hip or knee arthroplasty 
patients and 6 other registries collected PROMs for sample 
populations; 1 other registry had planned but had not started 
collection of PROMs (Table). The registries most often col-
lected PROMs for research (n = 10), quality assurance (n = 
8), or hospital assessment (n = 8). Some programs integrated 
their PROMs program in the clinic to provide input to caregiv-
ers for the care of individual patients (n = 6). Some registries 
used PROMs programs for assessment of surgeons (n = 4) and 
health regions (n = 4).
Different instruments were used by different registries 
(Table). The most common generic instruments were the 
EuroQol 5-dimension health outcome survey (EQ-5D) (Euro-
Qol Group 1990, EuroQol Group 2015) and the Short Form 
12 health survey (SF-12) or the VR-12, which is similar (Ware 
et al. 1992, Ware et al. 1996, Kosinski et al. 1999, Rolfson et 
al. 2011b, Boston University School of Public Health 2015, 
Optum Inc. 2015). 9 registries (60%) collected a satisfaction 
item. The most common specifi c PROMs were the Hip dis-
ability and Osteoarthritis Outcome Score (HOOS) (Nilsdot-
ter et al. 2003), the Knee injury and Osteoarthritis Outcome 
Score (KOOS) (Roos et al. 1998), the Oxford Hip Score 
(OHS) (Dawson et al. 1996, Murray et al. 2007), the Oxford 
Knee Score (OKS) (Dawson et al. 1998, Murray et al. 2007), 
the Western Ontario and McMaster Universities Arthritis 
Index (WOMAC) (Bellamy et al. 1988), and the University 
of California at Los Angeles Activity Score (UCLA) (Zahiri 
et al. 1998). Several registries reported use of a separate visual 
analog scale (VAS) or numeric rating scale (NRS) to measure 
joint pain (Breivik et al. 2000, Hawker et al. 2011, Hjerms-
tad et al. 2011). Most registries collected preoperative mea-
sures and had several follow-ups, most commonly at 1 year 
after surgery. Preoperative PROMs were usually collected at 
an outpatient visit or preoperative class. Follow-up surveys 
were usually collected by regular mail (printed forms), but 
some registries also used e-mail, electronic (web) surveys, 
and telephone calls. Response frequencies for PROMs were in 
some cases approximate estimates and should be interpreted 
with caution. The variation in frequency of patient responses 
refl ects the logistic challenges of collecting PROMs.
The ISAR PROMs Working Group thanks Elly Trepman for help in reorganiz-
ing the original ISAR PROMs Working Group internal report into 2 manu-
scripts.
All the authors participated in the conception of the study. OR and JD drafted 
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checking and revising the article critically for important intellectual content.
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Table 1. Survey responses of hip and knee arthroplasty registries that routinely collected patient-reported outcome measures a
  Joints    Frequency of Data
Registry  included b Patients PROMs collected Satisfaction patient response collection times
Type  Name Hip   Knee included c  Generic      Specifi c item  Preop.    Postop. Preop.   Postop.
National registries              
  Swedish Hip A R + – All EQ-5D Pain VAS Yes VAS 86 90 + 1, 6, 10 y
  National J R (through NHS)  + + All EQ-5D OHS/OKS Yes 80 80 + 6 mo
  Swedish Knee A R – + Sample EQ-5D KOOS,  Yes,   90 80 + 1 y
      pain VAS expectation
       fulfi llment
  New Zealand J R b + + Random  OHS/OKS – NA 70–75 – 6 mo,  
    20% sample       every 5 y
 Lithuanian A R + + Sample EQ-5D HOOS/KOOS – 100  60 + 6 mo, 1 y
        (of sample) 
  Norwegian A R + + Occasional EQ-5D HOOS/KOOS Yes NA 80 – 1 to 2 y
     cross-sectional
    samples
 Dutch A R b + + All EQ-5D,  OHS/OKS,  Yes 50 50 + 3 and 6 mo, 
     health pain NRS     1 y
     transition
National sample registries                
  FORCE-TJR + + All SF-36 HOOS/KOOS,  – 80–85 80–85 + 6 mo, 
      pain VAS     annually
  American J R + + Not started d EQ-5D,  WOMAC or – d d f f
     SF-12 or  HOOS/KOOS f    
     SF-36 e,f        
Local or regional registries              
  Harris J R + + All EQ-5D Pain VAS, HHS/ Yes VAS g g + 1, 3, 5, 7, 
      KOOS, UCLA     and 10 y
  Register of the  + – Sample EQ-5D HOOS Yes 30 80 + 1 y
 Orthopaedic Prosthetic 
 Implants (Italy)–
  Michigan A R + + All SF-12 e WOMAC, UCLA  32 12 + Annually
  Geneva A R + + All SF-12 e WOMAC,  Yes,  71 65 + 1, 5, 10, 
      Pain VAS, UCLA willingness    and 15 y
       to repeat
  Hospital for  + + All SF-12 e HOOS/KOOS Yes 80 75 + Annually
 Special Surgery
  California J R + + All SF-12 e WOMAC, UCLA – 70 70 + 6 mo, 1 y,   
           every 2 y
 
a
 n = 15 registries (7 national registries, 2 national samples, and 6 local or regional registries). The survey was performed in September 2014.
 A R: Arthroplasty Register/Registry, J R: Joint (Replacement) Register
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arthroplasty.
c Patients included: all, all patients in a country, region or hospital; sample, sample of patients in a country, region, or hospital. 
d Not started; the American Joint Replacement Register were planning but had not started a PROMs program as of September 2014.  
e SF-12 or the similar Veterans RAND 12-item health survey (VR-12).
f As preferred by healthcare provider.
g Not Known
EQ-5D, EuroQol 5-dimension health outcome survey; FORCE-TJR, Function and Outcomes Research for Comparative Effectiveness in Total 
Joint Replacement; NA, not applicable, NHS, National Health Service, England; HOOS, Hip disability and Osteoarthritis Outcome Score; 
KOOS, Knee injury and Osteoarthritis Outcome Score; NRS, numeric rating scale; OHS, Oxford Hip Score; OKS, Oxford Knee Score; SF-12 
(or 36), Short Form 12 (or 36) health survey; PROMs, patient-reported outcome measures; UCLA, University of California at Los Angeles 
Activity Score; VAS, Visual Analog Scale; WOMAC, Western Ontario and McMaster Universities Arthritis Index.
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